NOXXON Pharma (ENXTPA:ALNOX) | 合法醫療器材資訊網
IsNOXXONPharmaundervaluedcomparedtoitsfairvalueanditspricerelativetothemarket?2.23x.PricetoBook(PB)ratio.SharePricevs.FairValue.
About the CompanyTME Pharma N.V., a clinical-stage biopharmaceutical company, focuses on the development of proprietary therapeutics for the treatment of cancer in Germany. Its Spiegelmer platform has a proprietary pipeline of clinical-stage product candidates, including its lead cancer drug candidate, NOX-A12, which is under development as a combination therapy for various cancer indications, such as metastatic pancreatic and colorectal cancer, glioblastoma, and myeloma. It is also developing NOX-E36, which has completed Phase 1/2 clinical trial for the treatment of diabetic nephropathy.
Show moreALNOX | 合法醫療器材資訊網
NOXXON (ALNOX.PA) Stock Price | 合法醫療器材資訊網
NOXXON and the Market | 合法醫療器材資訊網
NOXXON Pharma | 合法醫療器材資訊網
NOXXON Pharma (ENXTPA:ALNOX) | 合法醫療器材資訊網
NOXXON PHARMA € 0.3594 | 合法醫療器材資訊網
NOXXON PHARMA € 0.3642 | 合法醫療器材資訊網
NOXXON PHARMA € 0.3652 | 合法醫療器材資訊網
【“術倍佳”沛帝佳脊椎聲光防護系統】許可證字號:衛部醫器輸字第027115號
器材品名:“術倍佳”沛帝佳脊椎聲光防護系統許可證字號:衛部醫器輸字第027115號註銷狀態:註銷日期:註銷理由:有效日期:2020/05/...
【“術倍佳”配提佳神經防護定位裝置】許可證字號:衛部醫器輸字第031395號
器材品名:“術倍佳”配提佳神經防護定位裝置許可證字號:衛部醫器輸字第031395號註銷狀態:註銷日期:註銷理由:有效日期:2023/08/...